Rhumbline Advisers Glaukos Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Glaukos Corp stock. As of the latest transaction made, Rhumbline Advisers holds 141,790 shares of GKOS stock, worth $17.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
141,790
Previous 141,387 0.29%
Holding current value
$17.8 Million
Previous $18.4 Million 15.42%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
BUY
$126.42 - $152.67 $50,947 - $61,526
403 Added 0.29%
141,790 $21.3 Million
Q3 2024

Nov 12, 2024
BUY
$113.62 - $135.39 $33,631 - $40,075
296 Added 0.21%
141,387 $18.4 Million
Q2 2024

Aug 01, 2024
BUY
$89.48 - $118.35 $454,468 - $601,099
5,079 Added 3.73%
141,091 $16.7 Million
Q1 2024

May 09, 2024
SELL
$76.4 - $96.33 $156,696 - $197,572
-2,051 Reduced 1.49%
136,012 $12.8 Million
Q4 2023

Feb 08, 2024
SELL
$59.53 - $85.11 $194,305 - $277,799
-3,264 Reduced 2.31%
138,063 $11 Million
Q3 2023

Nov 09, 2023
BUY
$69.23 - $79.09 $62,791 - $71,734
907 Added 0.65%
141,327 $10.6 Million
Q2 2023

Aug 08, 2023
SELL
$45.44 - $71.21 $6,906 - $10,823
-152 Reduced 0.11%
140,420 $10 Million
Q1 2023

May 11, 2023
BUY
$43.88 - $52.48 $363,238 - $434,429
8,278 Added 6.26%
140,572 $7.04 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $116,786 - $165,222
2,861 Added 2.21%
132,294 $5.78 Million
Q3 2022

Nov 10, 2022
BUY
$46.84 - $58.49 $264,973 - $330,877
5,657 Added 4.57%
129,433 $6.89 Million
Q2 2022

Aug 11, 2022
BUY
$34.86 - $63.77 $205,360 - $375,669
5,891 Added 5.0%
123,776 $5.62 Million
Q1 2022

May 12, 2022
BUY
$44.33 - $57.82 $302,197 - $394,158
6,817 Added 6.14%
117,885 $6.82 Million
Q4 2021

Feb 10, 2022
BUY
$40.27 - $56.99 $22,510 - $31,857
559 Added 0.51%
111,068 $4.94 Million
Q3 2021

Nov 12, 2021
SELL
$47.43 - $84.23 $817,693 - $1.45 Million
-17,240 Reduced 13.5%
110,509 $5.32 Million
Q2 2021

Aug 05, 2021
BUY
$73.06 - $97.7 $36,530 - $48,850
500 Added 0.39%
127,749 $10.8 Million
Q1 2021

May 06, 2021
BUY
$70.43 - $97.42 $132,971 - $183,928
1,888 Added 1.51%
127,249 $10.7 Million
Q4 2020

Feb 10, 2021
BUY
$48.9 - $75.26 $234,817 - $361,398
4,802 Added 3.98%
125,361 $9.44 Million
Q3 2020

Nov 12, 2020
SELL
$37.23 - $50.97 $213,662 - $292,516
-5,739 Reduced 4.54%
120,559 $5.97 Million
Q2 2020

Aug 13, 2020
BUY
$28.78 - $46.83 $29,240 - $47,579
1,016 Added 0.81%
126,298 $4.85 Million
Q1 2020

May 06, 2020
BUY
$25.53 - $70.14 $1.79 Million - $4.92 Million
70,108 Added 127.07%
125,282 $3.87 Million
Q4 2019

Feb 05, 2020
BUY
$54.18 - $65.64 $361,163 - $437,556
6,666 Added 13.74%
55,174 $3.01 Million
Q3 2019

Oct 23, 2019
SELL
$58.58 - $83.91 $69,475 - $99,517
-1,186 Reduced 2.39%
48,508 $3.03 Million
Q2 2019

Aug 14, 2019
BUY
$63.59 - $78.71 $276,680 - $342,467
4,351 Added 9.6%
49,694 $3.75 Million
Q1 2019

May 01, 2019
BUY
$50.75 - $80.54 $27,506 - $43,652
542 Added 1.21%
45,343 $3.55 Million
Q4 2018

Jan 31, 2019
BUY
$52.18 - $67.93 $773,725 - $1.01 Million
14,828 Added 49.47%
44,801 $2.52 Million
Q3 2018

Nov 07, 2018
SELL
$38.13 - $68.37 $77,327 - $138,654
-2,028 Reduced 6.34%
29,973 $1.95 Million
Q2 2018

Aug 06, 2018
BUY
$27.62 - $44.51 $134,896 - $217,386
4,884 Added 18.01%
32,001 $1.3 Million
Q1 2018

May 02, 2018
SELL
$26.05 - $34.5 $15,109 - $20,010
-580 Reduced 2.09%
27,117 $836,000
Q4 2017

Feb 09, 2018
SELL
$24.5 - $36.01 $125,366 - $184,263
-5,117 Reduced 15.59%
27,697 $710,000
Q3 2017

Nov 06, 2017
BUY
$31.26 - $42.03 $1.03 Million - $1.38 Million
32,814
32,814 $1.08 Million

Others Institutions Holding GKOS

# of Institutions
354
Shares Held
50M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.99B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email